SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Nick who wrote (463)1/14/1998 7:56:00 PM
From: RavBruce  Respond to of 1580
 
Remember that Merck is a Dow stock. Some of its movements
are tied to market/Dow moves.
Merck is a company that should excite any long-term investor.
It is always spends tons of money on R&D and is very well
managed. I recently read that they payed off all debt from
the Medco purchase of a few years ago.
Bruce



To: Nick who wrote (463)1/14/1998 9:16:00 PM
From: James Baker  Respond to of 1580
 
Nick and Rick,
Have you seen any IMS data on prescriptions for Propecia? I believe the weekly data was released today and good Propecia launch may account for the great gains the last two days to all time new high.
Jim



To: Nick who wrote (463)1/15/1998 2:35:00 AM
From: auco7  Read Replies (1) | Respond to of 1580
 
Nick,

I think Propecia has great potential. The side effects really do not concern me that much because the sexual side effect rates are low and many men will do anything to get their hair back. Even spend thousands of dollars on rugs!!!! My only concern is that I think many HMO will not cover this drug on their formularies since it is used for cosmetic use. I do suspect many healthy bald men will develop BPH though.

AUCO


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News